A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults

NCT07819097 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer